First-In-Human Study of KHN922 for Injection

Clinical trial NCT07514975 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07514975
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer

Start date: 2026-04-01
Primary completion: 2028-04-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.